Company News
Pfizer, Arvinas FDA Approve Veppanu Breast Cancer Pill
FDA grants approval to Pfizer and Arvinas' oral breast cancer drug Veppanu for advanced ER‑positive, HER2‑negative tumors.
Late‑stage trial of 624 patients showed longer progression‑free survival and
